Alembic Pharmaceuticals Ltd.

APLLTD

₹880.55

-0.37% (-3.25)

Market Cap

₹17,326 Cr.

P/E

28.65

About

Alembic Pharmaceuticals Limited, a flagship company of the Alembic Group, is engaged in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients. W… Read more

Alembic Pharmaceuticals Limited, a flagship company of the Alembic Group, is engaged in manufa… Read more

Low

725

52W Range

High

1304

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

13 Yes

Positive for this company

0 Neutral

Neutral for this company

4 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Promoter Holding

Promoter has been buying shares from the open market over last 90 days
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Company is converting accounting profit to cash
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Asset turnover is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Working Capital

Working capital of the company seems to be under control
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Debt

Company should not have issues servicing its debt
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Market Share

1.40 %

(as of Jun 23)

Historic

Anti - Diabetes - Market Share

2.10 %

(as of Jun 23)

Historic

Anti-Infectives - Market Share

0.14 %

(as of Nov 21)

Historic

Anti-Malarial - Market Share

0.01 %

(as of Nov 21)

Historic

Antineo Plastic - Market Share

0.26 %

(as of Nov 21)

Historic

Blood Related - Market Share

1.80 %

(as of Jun 23)

Historic

Cardiovascular - Market Share

4.20 %

(as of Jun 23)

Source/Historic

Cold & Cough Medication Market Share

0.20 %

(as of Jun 23)

Source/Historic

Dermatology - Market Share

0.02 %

(as of Nov 21)

Historic

Endocrinology - Market Share

1.20 %

(as of Jun 23)

Historic

Gastro-Intestinal - Market Share

3.10 %

(as of Jun 23)

Source/Historic

Gynecology - Market Share

0.10 %

(as of Nov 21)

Historic

Neurological - Market Share

2 %

(as of Jun 23)

Source/Historic

Ophthalmology - Market Share

0.83 %

(as of Nov 21)

Historic

Pain - Market Share

1.50 %

(as of Jun 23)

Historic

Pharmaceutical Sector - Market Share

1.85 %

(as of Nov 21)

Historic

Respiratory - Market Share

3.67 %

(as of Nov 21)

Historic

Urology - Market Share

0.80 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up - Domestic Branded Formulation Business

Product Wise Break-Up

Product Wise Break-Up - Formulations

Location Wise Break-Up - API

Location Wise Break-Up - Formulations

Location Wise Break-Up

Therapeutic Area Break-Up

Acute vs Chronic - Formulations

Operational Metrics

US DMF Filings (.)
Source
Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Approved By USFDA (.)
Source
Number of ANDA's Filed in Latam
Source
Number of ANDA's Approved by Latam
Source
Number of ANDA's Filed in South Africa
Source
Number of ANDA's Approved by South Africa
Source
Number of ANDA's Filed in Australia
Source
Number of ANDA's Approved by Australia
Source
Number of ANDA's Filed in Canada
Source
Number of ANDA's Approved by Canada
Source
Number of ANDA's Filed in Europe
Source
Number of ANDA's Approved in Europe
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Brands

Azithral

Tellzy

Zeet

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

Suppliers

Shaily Engineering Plastics Ltd.
Aarti Drugs Ltd.
ICE Make Refrigeration Ltd.
Bharat Parenterals Ltd.
Hindusthan National Glass & Industries Ltd.
Jocil Ltd.
Take Solutions Ltd.

Showing 5 of 7

FAQs on Alembic Pharmaceuticals Ltd. Business

What does Alembic Pharma do?

Alembic Pharmaceuticals Limited is a top pharmaceutical company in India known for its expertise in India Formulations, International Generics, and Active Pharmaceutical Ingredients. It excels in oncology, injectables, and ophthalmology.

Who are the competitors of Alembic Pharma?

Alembic Pharma major competitors are Natco Pharma, Sanofi India, Jubilant Pharmova, Eris Lifesciences, Caplin Point Lab, Pfizer, Astrazeneca Pharma I.
Market Cap of Alembic Pharma is ₹17,359 Crs.
While the median market cap of its peers are ₹15,137 Crs.

Is Alembic Pharma financially stable compared to its competitors?

Alembic Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Alembic Pharma is 9.51 and is ranked 5 out of its 8 competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep	Mar Jun Sep Dec	Mar Jun Sep Dec	Dec
Conference Call		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep Dec	Jun Sep Dec	Jun Sep Dec	Jun Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Alembic Pharmaceuticals Ltd.

View the discussion on ValuePickr

Corporate Governance Issues At Paushak - Smart Sync Services

Chemical Sector

Chemicals Sector - Breakdown and Value Chain - PPFAS

Chemical Industry - Top Down - Capital Mind

Battery Chemistry Of EV's - Value Educator

Indian agrichemical overview - a sectoral perspective - ValuePickr

Next MegaTrend in Investing : Is Methanol Next "Ethanol"? - Sadhan

Understanding the Agri-Inputs Industry - PPFAS

Pesticides Industry Primer - ValuePickr

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Alembic Pharmaceuticals Ltd.

Alembic Pharmaceuticals Ltd.

About

Timeline

Company Timeline

13 Yes

0 Neutral

4 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Other Income

Pledge

Promoter Holding

Retail Holding

Revenue Recognition

Depreciation Effect

Price & Performance

Capex vs ROCE

ROE

Share price

Working Capital

Current vs Historic Valuation

Debt

Balance Sheet Strength

Sales Growth

Margin Stability

ROCE Strength

Product Wise Break-Up - Domestic Branded Formulation Business

UNLOCK PREMIUM

Product Wise Break-Up

UNLOCK PREMIUM

Product Wise Break-Up - Formulations

UNLOCK PREMIUM

Location Wise Break-Up - API

UNLOCK PREMIUM

Location Wise Break-Up - Formulations

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Therapeutic Area Break-Up

UNLOCK PREMIUM

Acute vs Chronic - Formulations

UNLOCK PREMIUM

What does Alembic Pharma do?

Who are the competitors of Alembic Pharma?

Is Alembic Pharma financially stable compared to its competitors?

SIGN UP FOR FREE